Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Dentsply Sirona
XRAY
$2.17B
| $18.4M | 0.04% |
364,836
+244,997
| +204% | +$13M |
|
602
Honeywell
HON
$68.1B
| $18.4M | 0.04% |
216,569
-110,582
| -34% | -$10.1M |
|
603
JB Hunt Transport Services
JBHT
$24.4B
| $18.4M | 0.04% |
257,507
-610,799
| -70% | -$48.4M |
|
|
HIFR
604
DELISTED
InfraREIT, Inc.
HIFR
| $18.4M | 0.04% |
776,454
-242,866
| -24% | -$7.11M |
|
605
Silicon Motion
SIMO
$8.25B
| $18.2M | 0.04% |
667,376
+53,038
| +9% | +$1.42M |
|
|
CNCE
606
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $18.2M | 0.04% |
971,019
+406,209
| +72% | +$6.9M |
|
607
HEICO Corp
HEI
$49.3B
| $18.2M | 0.04% |
910,203
+600,777
| +194% | +$13.1M |
|
608
Allegiant Air
ALGT
$2.23B
| $18.2M | 0.04% |
84,137
+83,131
| +8,264% | +$17.4M |
|
|
QTS
609
DELISTED
QTS REALTY TRUST, INC.
QTS
| $18.1M | 0.04% |
414,490
-207,839
| -33% | -$8.48M |
|
|
SNBR
610
DELISTED
Sleep Number
SNBR
| $18.1M | 0.04% |
827,308
+390,995
| +90% | +$9.98M |
|
611
Spectrum Brands
SPB
$2.03B
| $18.1M | 0.04% |
197,651
+81,216
| +70% | +$8.08M |
|
612
TripAdvisor
TRIP
$1.19B
| $18.1M | 0.04% |
286,969
+72,604
| +34% | +$5.49M |
|
613
Tenet Healthcare
THC
$22.4B
| $18.1M | 0.04% |
488,915
-1,204,769
| -71% | -$62.2M |
|
|
DF
614
DELISTED
Dean Foods Company
DF
| $18M | 0.03% |
1,091,736
-1,210,012
| -53% | -$20.7M |
|
615
XPO
XPO
$22.5B
| $18M | 0.03% |
2,186,651
-2,146,690
| -50% | -$28.2M |
|
616
The GEO Group
GEO
$4.24B
| $17.9M | 0.03% |
902,465
-144,565
| -14% | -$3.19M |
|
617
Revvity
RVTY
$13.7B
| $17.8M | 0.03% |
388,301
+225,306
| +138% | +$11.2M |
|
618
Textron
TXT
$14.1B
| $17.8M | 0.03% |
473,990
-173,251
| -27% | -$7.18M |
|
619
CubeSmart
CUBE
$9.21B
| $17.8M | 0.03% |
654,215
+178,681
| +38% | +$4.57M |
|
|
CCP
620
DELISTED
Care Capital Properties, Inc.
CCP
| $17.8M | 0.03% |
+540,496
| New | +$17.5M |
|
|
AERI
621
CALL
DELISTED
Aerie Pharmaceuticals
AERI
| $17.7M | 0.03% |
+1,000,000
| New | +$18.1M |
|
622
Zebra Technologies
ZBRA
$17.2B
| $17.7M | 0.03% |
231,463
+101,464
| +78% | +$9.57M |
|
|
CEMP
623
DELISTED
Cempra, Inc.
CEMP
| $17.6M | 0.03% |
632,252
+438,476
| +226% | +$16.3M |
|
624
PUT
Charter Communications
CHTR
$17.9B
| $17.6M | 0.03% |
100,000
| – | – |
|
625
NCR Voyix
VYX
$1.1B
| $17.6M | 0.03% |
1,259,501
+119,955
| +11% | +$2M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.